A new nasal spray-based gene therapy, using AAV.CPP.16 shows promise for treating lung diseases like COVID-19 and pulmonary fibrosis. Scientists engineered a way to deliver genes directly to lung ...

The new molecule, delivered via nasal spray, triggers "mucosal immunity" which coats the tissue lining organs and tracts before a virus can enter. Tests in mice showed the antibody protected ...

HANOI, VN / ACCESS Newswire / May 19, 2025 / LiveSpo® NAVAX - a nasal-spray probiotic product developed ... reinforcing a promising new direction in non-antibiotic respiratory care.

HANOI, VIETNAM - Media OutReach Newswire - 19 May 2025 - LiveSpo® NAVAX - a nasal-spray probiotic product developed by Vietnamese ... reinforcing a promising new direction in non-antibiotic ...

In a new study, Yale researchers have found that ... "These data imply that viral proteins in nasal spray may be used as a safe way to promote antiviral immunity at the site of viral entry." ...

That’s what a new study from researchers at The Ohio State ... Instead of injecting it into the bloodstream, researchers turned it into a nasal spray. This strategy allowed the antibody to ...

(MENAFN- Media OutReach Newswire) HANOI, VIETNAM - Media OutReach Newswire - 19 May 2025 - LiveSpo® NAVAX – a nasal-spray probiotic ... reinforcing a promising new direction in non-antibiotic ...

To improve the AAV’s ability to deliver therapeutics specifically to the lungs and airway, Mass General Brigham researchers developed and applied a new version, called AAV.CPP.16, that can be ...

(MENAFN- The Arabian Post) HANOI, VIETNAM – Media OutReach Newswire – 19 May 2025 – LiveSpo® NAVAX – a nasal-spray probiotic ... reinforcing a promising new direction in non-antibiotic ...

T he U.S. Food and Drug Administration has approved a nasal spray to treat depression—the first-ever stand-alone medication for patients with severe depression.Johnson & Johnson said patients ...